Is HIF-1α a valid therapeutic target?

Roberto Pili; Ross C. Donehower

doi:10.1093/jnci/95.7.498

Is HIF-1α a valid therapeutic target?

Roberto Pili, Ross C. Donehower

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	498-499
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	95
Issue number	7
DOIs	https://doi.org/10.1093/jnci/95.7.498
State	Published - Apr 2 2003

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/95.7.498

Cite this

@article{439aa0a0dcfb429a95edfd41de7fe4f2,

title = "Is HIF-1α a valid therapeutic target?",

author = "Roberto Pili and Donehower, {Ross C.}",

year = "2003",

month = apr,

day = "2",

doi = "10.1093/jnci/95.7.498",

language = "English (US)",

volume = "95",

pages = "498--499",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",